# A Long-Term Safety Study of ALKS 5461

> **NCT02141399** · PHASE3 · COMPLETED · sponsor: **Alkermes, Inc.** · enrollment: 1485 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** ALKS 5461

## Key facts

- **NCT ID:** NCT02141399
- **Lead sponsor:** Alkermes, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2017-11-20
- **Final completion:** 2017-11-20
- **Target enrollment:** 1485 (ACTUAL)
- **Last updated:** 2018-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141399, "A Long-Term Safety Study of ALKS 5461". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02141399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*